Categories: Awards

Hamdard Laboratories India bags prestigious international award for cGMP

New Delhi, October 20, 2022: Hamdard Laboratories India – the world’s largest manufacturer of Unani medicines, has bagged ‘the 2nd International Sheikh Zayed Award 2022’ for ‘Traditional, Complementary & Alternative Medicine’ (TCAM) in the category of cGMP at Abu Dhabi. TCAM awards were institutionalized to honor the prominent TCAM Academics and Scientists worldwide for their exceptional achievements in improving the quality of life for mankind, as well as for significantly contributing to advancing TCAM knowledge and practices internationally.

Hamdard Laboratories India received the prize for its contribution to globalizing the AYUSH system. Hamdard Laboratories India Trustee Mr. Asad Mueed received the award on behalf of the Hamdard Laboratories India family.

Mr. Asad Mueed, Executive Trustee, Hamdard Laboratories, on receiving the award, stated, “Aligned with the Government of India’s vision, We at Hamdard Laboratories India are on a mission to take AYUSH practices to the global level with scientific evidence, and such international recognitions will help people understand the strength of various traditional systems and highest quality standards that Indian companies are maintaining.  We are thankful to the Indian government for its continual encouragement and support of the entire AYUSH industry. This esteemed Sheikh Zayed International Award for Best Manufacturing Practices is a great honor for our company and will encourage us to continue with the same zeal”.

“During COVID, we conducted clinical research at our medical college HIMSR on two of our patented medications and discovered a substantial effect for the preventive potential of these Unani formulations. The findings of the study were published in the peer-reviewed journal Phytotherapy Research” he further added.

Hamdard Laboratories India is a progressive, research-based Unani pharmaceutical company, which was founded in 1906 by Hakeem Hafiz Abdul Majeed in undivided India’s capital, Delhi, and has state of art facilities in Ghaziabad UP.

Hamdard Laboratories India has received several honours for its Ghaziabad plant, including the ISO 9001-2015, quality management standard ISO 22099-2018 food and safety management standard, certificate of good manufacturing practices-Unani medication production licence.

In addition, Hamdard’s Okhla production plant is GMP, ISO 9001-2015 certified for quality management system standards, ISO 22000-2018 accredited for food and safety management system, and Ayush Standard Mark approved for the manufacture and delivery of Unani goods.

Hamdard is also working towards integrating traditional and Conventional medicines and time will unveil its story.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

17 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

17 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

1 day ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

3 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago